Metastatic Sau Uku-Karɓan Ciwon Nono: Sabon Magani

0 banza 3 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

 Everest Medicines, wani kamfani na biopharmaceutical da ke mayar da hankali kan haɓakawa da kasuwancin samfuran magunguna masu canzawa don magance mahimman buƙatun da ba a cika su ba a kasuwannin Asiya Pacific, ya sanar a yau cewa Hukumar Kimiyyar Kiwon Lafiya (HSA) ta Singapore ta amince da Trodelvy® (sacituzumab govitecan ko SG) don maganin manya marasa lafiya tare da ci-gaba na gida ko metastatic sau uku-negative ciwon nono (mTNBC) waɗanda suka sami biyu ko fiye da tsarin jiyya na farko, aƙalla ɗaya daga cikinsu don cutar ta metastatic. Wannan shine farkon amincewar magani na Trodelvy da Everest ya samu. Kamfanin yana tsammanin jerin yarda ga Trodelvy a cikin yankunan lasisinsa a cikin shekara mai zuwa.

"A matsayin wani ɓangare na dabarun kasuwancinmu mafi girma don gina ingantacciyar kasuwancin kasuwanci a kasuwannin Asiya Pacific, muna da kyakkyawan matsayi don haɓaka cikin sauri yayin wannan ci gaba na gaba tare da ƙungiyar kasuwanci da aka kafa, tare da daidaita rata tsakanin marasa lafiya da buƙatun likita da farko. -in-class biopharmaceutical bidi'a, "in ji Kerry Blanchard, MD, PhD, Babban Jami'in Harkokin Magungunan Everest. "A matsayin mataki na gaba za mu yi aiki tare tare da duk masu ruwa da tsaki don kawo Trodelvy ga mata a Singapore masu fama da cutar ta TNBC." 

“TNBC ita ce ke da kashi 15-20 cikin XNUMX na duk masu fama da cutar kansar nono a Singapore, kuma sankarar nono ita ce kan gaba wajen mutuwar mata a kasar. Wannan mummunan nau'i na cutar da ke da wuyar magancewa a tarihi yana da iyakataccen zaɓin magani, tare da rayuwa gabaɗaya ba ta canzawa a tsakanin marasa lafiya kusan shekaru ashirin, "in ji Yang Shi, Babban Jami'in Lafiya na Oncology a Magungunan Everest. Wannan babban ci gaba na tsari yana kawo matakin Trodelvy kusa da marasa lafiya na Singapore tare da TNBC metastatic.

Baya ga Singapore, Everest yana ba da haɗin kai tare da hukumomin gudanarwa a cikin Babban China da Koriya ta Kudu don sake duba aikace-aikacen sa na Trodelvy ga manya marasa lafiya waɗanda ke da ci gaba a cikin gida ko na TNBC waɗanda suka karɓi tsarin jiyya biyu ko fiye da suka gabata, aƙalla ɗaya daga cikinsu don metastatic cuta.

• A watan Mayun 2021, Hukumar Kula da Kayayyakin Kiwon Lafiyar Jama'a ta kasar Sin ta karɓi aikace-aikacen lasisin nazarin halittu don Trodelvy tare da bitar fifiko.

• A cikin Disamba 2021, Ma'aikatar Abinci da Kare Magunguna (MFDS) na Koriya ta Kudu ta karɓi Sabuwar Aikace-aikacen Magunguna (NDA) don Trodelvy. A baya an ba Trodelvy Nazari mai sauri da Tsarin Magungunan Marayu a Koriya ta Kudu.

• A cikin Disamba 2021, Hukumar Abinci da Magunguna ta Taiwan ta karɓi NDA don Trodelvy. A baya an ba Trodelvy Likitan Yara da Ƙwararren Ƙwararrun Ƙwararrun Magani a Taiwan.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...